Petros Pharmaceuticals, Inc. (PTPI) Operating cash flow 2020–2025
Petros Pharmaceuticals, Inc. (PTPI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.7MFY2025 · since FY2020: -$15.3M → -$6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.7M | -158.7% |
| FY2024 | -$2.6M | +65.9% |
| FY2023 | -$7.6M | +40.4% |
| FY2022 | -$12.8M | -7.9% |
| FY2021 | -$11.9M | +22.5% |
| FY2020 | -$15.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice